Jane Huang
Overview
Jane Huang received $3M in total compensation, including $392K in salary, at Prelude Therapeutics in 2022. Jane Huang also received an average of $3M at BeiGene, Ltd. from 2017 to 2019.
Source: SEC filings on April 28, 2023, April 28, 2020, April 29, 2019, and April 30, 2018.
Related executives
We found 11 more executives who work or worked at Prelude Therapeutics and BeiGene, Ltd..
Krishna Vaddi
Prelude Therapeutics
Chief Executive Officer
Peggy Scherle
Prelude Therapeutics
Chief Scientific Officer
Brian Piper
Prelude Therapeutics
Chief Financial Officer
Andrew Combs
Prelude Therapeutics
EVP and Head of Chemistry
John Oyler
BeiGene, Ltd.
Chief Executive Officer
Xiaobin Wu
BeiGene, Ltd.
General Manager of China and President
Howard Liang
BeiGene, Ltd.
Chief Financial Officer
Amy Peterson
BeiGene, Ltd.